In English, this would translate to: China's innovation in pharmaceutical manufacturing already accounts for 38% of the global market. China has also developed innovative drugs that can potentially reverse diabetes.

On August 16th, at the Lujiazui Financial Salon, Chen Li, the chairman of Hualing Pharmaceutical Technology Co., Ltd., stated that currently, innovative drugs manufactured in China account for 38% of the global market. Last year, there were 39 new innovative drugs launched, and in the first half of this year, 30 have already been launched. China has the capability to develop globally pioneering innovative drugs, such as Hualing Pharmaceutical's Huatangning, which uses advanced scientific concepts and technology to create a new drug that can reverse diabetes and prevent its complications. This innovative product has successfully entered the market in China and is covered by health insurance.